Pfizer Bio-N-Tech vaccination
The European Medicines Agency is likely to approve a Covid-19 vaccine for use in children aged 12-15, later today.
The use of the Pfizer Bio-N-Tech inoculation is being reviewed by the Europeans Medicines Agency.
Similar approval was granted in the US earlier this month.
